Marked Efficacy Of Rituximab In Two Patients With Waldenstrom Macroglobulinemia-Like Multiple Myeloma.

Christoph J. Heuck,Saad Zafar Usmani,Erming Tian,Qing Zhang,Frits Van Rhee,Sarah Waheed,Bijay P. Nair,Nathan Petty,Xenofon Papanikolaou,John D. Shaughnessy,Bart Barlogie

JOURNAL OF CLINICAL ONCOLOGY（2012）

引用 0|浏览14

暂无评分

摘要

e18548 Background: Rituximab (R) has been deemed to be ineffective in multiple myeloma (MM), despite CD20 expression in 10-15% of MM. Here we report two cases, selected by a genomic approach, with ...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要